Tonix Pharmaceuticals
0 followers
Tonix is developing innovative pharmaceutical products to address major public health challenges. In addition to Tonmya for PTSD, Tonix is developing TNX-601 (tianeptine oxalate), a clinical candidate at pre-IND (Investigational New Drug) application stage, designed as a daytime treatment for PTSD,... Read more
Org chart
Seth Lederman
Co-Founder, CEO & Chairman
Seth Lederman
Collapse
Gregory Sullivan
Chief Medical Officer
Darryl Rideout
EVP, Experimental Chemistry
Siobhan Fogarty
EVP, Product Development
Sina Bavari
EVP, Infectious Disease Research & Development
Anthony MacAluso
Executive Vice President, Strategic Development
Scott Szymanski
VP Sales And Marketing (migraine)
Jean Engels
Director Of Biostatistics
Ram Patalapati
Head, R&d Quality
Stephanie Valdez Trefry
Senior Research Associate
